Health Catalyst, Inc. (HCAT)

NASDAQ: HCAT · USD

$1.81

+0.24 (+15.3%)· Recorded snapshot

Market cap	136.2M
Revenue (ttm)	292.2M
Net income (ttm)	-264.8M
EPS (ttm)	-$3.68
Shares out	75.3M
Volume	666,830
Beta	1.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 292.2M
Net income (ttm): -264.8M
EPS (ttm): -$3.68
Market cap: 136.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-118.1

P25 -113.8P50 -46.5P75 -0.9

ROIC-3.7

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All HCAT indicators

Market & fundamental data

Available fields

225

Groups with data

Currency

USD

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001636422
Company name	Health Catalyst, Inc.
Country	United States
Country code	US
CUSIP number	42225T107
Earnings date	2026-11-05
Earnings time	amc
Employees	1,200
Employees change	-300
Employees growth	-20%
Enterprise value	$202.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2008
Industry	Health Information Services
IPO date	2019-07-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US42225T1079
Last 10-K release date	2026-03-12
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$136.2M
Market cap category	Micro-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$1.81
Price currency	USD
Sector	Healthcare
SIC code	7370
Stock price date	2026-10-28
Symbol	HCAT
U.S. state	Utah
Website	https://www.healthcatalyst.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	9.05x
Earnings yield	-203.23%
EV/EBITDA	17.29x
EV/FCF	7.53x
EV/Sales	0.7x
FCF / EV yield	13.28%
FCF yield	19.73%
Forward EV/Sales	0.97x
Forward P/S	0.65x
Industry forward P/E	34.62x
P/(FCF - SBC) ratio	14.57x
P/(OCF - SBC) ratio	12.91x
P/B ratio	1.16x
P/FCF ratio	5.07x
P/OCF ratio	4.85x
P/S ratio	0.47x
Price / tangible book value	4.08x
Price/EBITDA ratio	11.64x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-8.05%
EBITDA margin	4.03%
FCF margin	9.25%
Gross margin	51.16%
Operating margin	-8.05%
Pretax margin	-90.22%
Profit margin	-90.61%
Profit per employee	$-220,681
Revenue per employee	$243,538
ROA	-3.02%
ROA (5Y)	-7.32%
ROCE	-8.82%
ROE	-118.12%
ROE (5Y)	-34.9%
ROIC	-3.72%
SBC / revenue	6.03%
Tax / revenue	0.39%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	2.83%
Gross profit growth (Q)	-7.94%
Gross profit growth 3Y	3.46%
Gross profit growth 5Y	6.79%
Net income growth quarters	1
Net income growth years	0
OCF growth (QoQ)	-98.51%
Revenue growth	-7.55%
Revenue growth (Q)	-12.68%
Revenue growth (QoQ)	-0.38%
Revenue growth 3Y	0.89%
Revenue growth 5Y	6.24%
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.2M
Depreciation and amortization	$35.3M
EBIT	$-23.5M
EBITDA	$11.8M
EPS	$-3.68
FCF per share	$0.36
Financing cash flow	$-1.4M
Free cash flow	$27M
Free cash flow minus SBC	$9.4M
Gross profit	$149.5M
Income taxes	$1.1M
Investing cash flow	$-16.8M
Net borrowing	$-2.3M
Net cash flow	$9.9M
Net income	$-264.8M
Operating cash flow minus SBC	$10.6M
Operating income	$-23.5M
Revenue	$292.2M
Stock-based compensation	$17.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-4.4
Book value per share	$1.35
Debt / EBITDA	13.59
Debt / equity	1.69
Debt / FCF	6.29
Goodwill	$11.1M
Interest coverage	-1.15
Long-term assets	$110.2M
Long-term liabilities	$165.9M
Net cash (debt)	$-66.5M
Net cash / market cap	-48.58%
Net debt / EBITDA	5.65
Net debt / equity	0.66
Net debt / FCF	2.46
Piotroski F-Score	5
Property, plant and equipment	$39.4M
Shareholders' equity	$100.8M
Tangible book value	$33.6M
Tangible book value per share	$0.45
Total assets	$358.6M
Total cash	$103.4M
Total debt	$170M
Total liabilities	$257.8M
WACC	10.96%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.6
Current assets	$248.4M
Current liabilities	$91.9M
Current ratio	2.7
Net working capital	$58.4M
Quick ratio	1.58
Working capital	$156.5M
Working capital turnover	2.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-10.32%
Dividend yield	0%
Shareholder yield	-10.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.67
1D price change	15.29%
1M price change	4.02%
1M total return	4.02%
1W price change	4.02%
1W total return	4.02%
1Y price change	-47.69%
1Y return CAGR	-47.71%
1Y total return	-47.69%
20-day SMA	$1.73
200-day SMA	$1.72
3M price change	-15.81%
3M total return	-15.81%
3Y price change	-73.62%
3Y return CAGR	-35.86%
3Y total return	-73.62%
50-day SMA	$1.72
50-day SMA vs 200-day SMA	50under200
52-week high	$3.62
52-week high date	2025-10-29
52-week low	$0.96
52-week low date	2026-04-10
5Y price change	-96.37%
5Y return CAGR	-48.48%
5Y total return	-96.37%
6M price change	32.12%
6M total return	32.12%
All-time high	$59.50
All-time high date	2021-06-09
All-time low	$0.96
All-time low date	2026-04-10
Average true range (ATR)	$0.09
Average volume	381.2K
Beta (1Y)	1.72
Beta (2Y)	1.35
Beta (5Y)	1.54
Change from 52-week high	-49.93%
Change from 52-week low	89.51%
Change from all-time high	-96.96%
Change from all-time low	89.51%
Change from open	9.37%
Day's gap	5.41%
Dollar volume	$1.2M
High price	$1.83
Low price	$1.64
Monthly RSI	32.88
Open price	$1.66
Position in 52-week range	89.74%
Premarket change	1.91%
Premarket close	$1.57
Premarket price	$1.60
Previous close	$1.57
Price vs 150-day SMA	8.19%
Price vs 20-day SMA	4.44%
Price vs 200-day SMA	5.17%
Price vs 50-day SMA	5.54%
Relative volume	1.79
Return from IPO open	-95.15%
Return from IPO price	-93%
RSI	56.04
Sharpe ratio	-0.33
Sharpe ratio (3Y)	-0.31
Sharpe ratio (5Y)	-0.6
Sortino ratio	-0.44
Sortino ratio (3Y)	-0.39
Sortino ratio (5Y)	-0.78
Volume	666.8K
Weekly RSI	50.02
YTD price change	-24.27%
YTD total return	-24.27%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	59.3M
Float percentage	78.76%
Shares change (QoQ)	1.88%
Shares change (YoY)	10.32%
Shares held by insiders	5.65%
Shares held by institutions	64.1%
Shares outstanding	75.3M
Short % of float	3.73%
Short % of shares	2.94%
Short ratio	4.8 days

Deeper analysis on HCAT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this HCAT report

Is a complete HCAT research report available?

No complete published report is available for Health Catalyst, Inc. (HCAT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Health Catalyst, Inc. (HCAT)

Price

Financial snapshot

Fair-value bridge

Latest news · HCAT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HCAT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HCAT

Frequently asked questions